• Je něco špatně v tomto záznamu ?

Prognostic Properties of the GOLD 2023 Classification System

K. Brat, M. Svoboda, J. Zatloukal, M. Plutinsky, E. Volakova, P. Popelkova, B. Novotna, T. Dvorak, V. Koblizek

. 2023 ; 18 (-) : 661-667. [pub] 20230420

Jazyk angličtina Země Nový Zéland

Typ dokumentu multicentrická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011739

INTRODUCTION: Recently, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published an update on the Global Strategy for Prevention, Diagnosis and Management of COPD, introducing a new classification of chronic obstructive pulmonary disease (COPD). Our aim was to assess the prognostic value of the new GOLD classification system in comparison with the previous GOLD classification systems (GOLD stages I-IV and GOLD groups A-D) and the BODE index. METHODS: We used the data of 784 patients with COPD from the Czech Multicenter Research Database of COPD. Patient survival was analyzed with the use of Kaplan-Meier estimate and Cox model of proportional risks. ROC analysis and area under curve (AUC) were used for comparison of GOLD classifications and BODE index. The analyses were performed with the use of software R (version 4.2.0). RESULTS: We analyzed data of 782 patients with complete data on GOLD classifications. The study population comprised 72.9% of men, 89.1% current or former smokers, with a mean age of 66.6 years, a mean BMI of 27.4 and a mean FEV1 44.9% of predicted. Probability of 5-year survival differed by GOLD classification. Application of the 2023 GOLD classification showed increased risk of death in group B (HR 1.82, 95% CI 1.14-2.92; p = 0.013) and in group E (HR 2.48, 95% CI 1.54-3.99; p˂0.001). The ROC analysis showed that the overall prognostic value of the 2023 GOLD classification was similarly weak to previous A-D GOLD classification schemes (AUCs 0.557-0.576) and was lower compared to the GOLD 1-4 system (AUC 0.614) and even lower when compared to the BODE index (AUC 0.715). CONCLUSION: We concluded that the new GOLD classification system has poor prognostic properties and that specific prediction tools (eg, the BODE index) should be used for mortality risk assessment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011739
003      
CZ-PrNML
005      
20230801133309.0
007      
ta
008      
230718s2023 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/COPD.S410372 $2 doi
035    __
$a (PubMed)37114105
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Brat, Kristian $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $1 https://orcid.org/000000031674228X
245    10
$a Prognostic Properties of the GOLD 2023 Classification System / $c K. Brat, M. Svoboda, J. Zatloukal, M. Plutinsky, E. Volakova, P. Popelkova, B. Novotna, T. Dvorak, V. Koblizek
520    9_
$a INTRODUCTION: Recently, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published an update on the Global Strategy for Prevention, Diagnosis and Management of COPD, introducing a new classification of chronic obstructive pulmonary disease (COPD). Our aim was to assess the prognostic value of the new GOLD classification system in comparison with the previous GOLD classification systems (GOLD stages I-IV and GOLD groups A-D) and the BODE index. METHODS: We used the data of 784 patients with COPD from the Czech Multicenter Research Database of COPD. Patient survival was analyzed with the use of Kaplan-Meier estimate and Cox model of proportional risks. ROC analysis and area under curve (AUC) were used for comparison of GOLD classifications and BODE index. The analyses were performed with the use of software R (version 4.2.0). RESULTS: We analyzed data of 782 patients with complete data on GOLD classifications. The study population comprised 72.9% of men, 89.1% current or former smokers, with a mean age of 66.6 years, a mean BMI of 27.4 and a mean FEV1 44.9% of predicted. Probability of 5-year survival differed by GOLD classification. Application of the 2023 GOLD classification showed increased risk of death in group B (HR 1.82, 95% CI 1.14-2.92; p = 0.013) and in group E (HR 2.48, 95% CI 1.54-3.99; p˂0.001). The ROC analysis showed that the overall prognostic value of the 2023 GOLD classification was similarly weak to previous A-D GOLD classification schemes (AUCs 0.557-0.576) and was lower compared to the GOLD 1-4 system (AUC 0.614) and even lower when compared to the BODE index (AUC 0.715). CONCLUSION: We concluded that the new GOLD classification system has poor prognostic properties and that specific prediction tools (eg, the BODE index) should be used for mortality risk assessment.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    _2
$a senioři $7 D000368
650    _2
$a prognóza $7 D011379
650    12
$a chronická obstrukční plicní nemoc $x diagnóza $x terapie $7 D029424
650    _2
$a progrese nemoci $7 D018450
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svoboda, Michal $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
700    1_
$a Zatloukal, Jaromir $u Pulmonary Department, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine, Palacky University, Olomouc, Czech Republic
700    1_
$a Plutinsky, Marek $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Volakova, Eva $u Pulmonary Department, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000263888022 $7 xx0223802
700    1_
$a Popelkova, Patrice $u Pulmonary Department, University Hospital Ostrava, Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000165724702
700    1_
$a Novotna, Barbora $u Pulmonary Department, Bulovka Hospital, Prague, Czech Republic
700    1_
$a Dvorak, Tomas $u Pulmonary Department, Mlada Boleslav Hospital, Mlada Boleslav, Czech Republic
700    1_
$a Koblizek, Vladimir $u Pulmonary Department, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $u Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000224462790 $7 xx0076215
773    0_
$w MED00165283 $t International journal of chronic obstructive pulmonary disease $x 1178-2005 $g Roč. 18, č. - (2023), s. 661-667
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37114105 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133305 $b ABA008
999    __
$a ok $b bmc $g 1963906 $s 1198004
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 18 $c - $d 661-667 $e 20230420 $i 1178-2005 $m International journal of COPD $n Int. j. chronic obstr. pulm. dis. $x MED00165283
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace